{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:07:28Z","timestamp":1791216448656,"version":"4.1.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by poor prognosis and limited responsiveness to conventional therapies. Increasing evidence shows that the reprogramming of glucose metabolism is a hallmark of cancer cells, supporting their rapid proliferation, metastatic potential, and therapy resistance. This metabolic shift is particularly pronounced in TNBC, where reliance on glycolysis is greater than in other breast cancer subtypes. Consequently, strategies that target glucose metabolic pathways may offer a promising means to overcome treatment resistance and improve clinical outcomes. In this review, we summarize the unique features and regulatory mechanisms of glycolytic reprogramming in TNBC, with attention to tumor heterogeneity and its implications for disease progression and treatment response. We highlight recent preclinical studies that evaluate therapeutic approaches designed to exploit metabolic vulnerabilities, including glycolysis inhibition, metabolic enzyme targeting, and combination regimens with radiotherapy. Collectively, these findings suggest that interventions aimed at glycolytic pathways hold considerable potential to enhance radiosensitivity in TNBC. We discuss the translational prospects of this research, emphasizing the value of glycolysis-related genes as predictive biomarkers and as foundations for the development of novel targeted agents. While preliminary evidence is encouraging, further validation is required to establish the safety, efficacy, and clinical applicability of these strategies in human patients. Continued research in this area is expected to contribute to the development of more effective therapeutic options, ultimately improving the management and prognosis of TNBC.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1715716","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:21:38Z","timestamp":1776745298000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucose metabolic reprogramming: a novel strategy to enhance radiotherapy response to triple-negative breast cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Lu","family":"Gan","sequence":"first","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]},{"name":"College of Nuclear Science and Technology, University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]},{"name":"Hospital of Stomatology, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Si","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]},{"name":"College of Nuclear Science and Technology, University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]},{"name":"College of Nuclear Science and Technology, University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Heavy Ion Radiation Biology and Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, China"]},{"name":"Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Institute of Modern Physics, Chinese Academy of Sciences","place":["Lanzhou, Gansu, China"]},{"name":"College of Nuclear Science and Technology, University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute for Radiological Science, National Institutes for Quantum Science and Technology (QST)","place":["Chiba, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","article-title":"Triple-negative breast cancer therapeutic resistance: where is the Achilles' heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e70803","DOI":"10.1002\/cam4.70803","article-title":"Targeting triple-negative breast cancer: resistance mechanisms and therapeutic advancements","volume":"14","author":"Raman","year":"2025","journal-title":"Cancer Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e35826","DOI":"10.1002\/cncr.35826","article-title":"\u201cCancer statistics, 2025\u201d provides data on cancer occurrence and outcomes","volume":"131","author":"Nierengarten","year":"2025","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3390\/cells9092064","article-title":"Breast cancer subtypes underlying EMT-mediated catabolic metabolism","volume":"9","author":"Cho","year":"2020","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.ymthe.2021.03.003","article-title":"Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers","volume":"29","author":"Yu","year":"2021","journal-title":"Mol Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.09.004","article-title":"Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies","volume":"131","author":"He","year":"2018","journal-title":"Crit Rev Oncol Hemat."},{"key":"B11","doi-asserted-by":"publisher","first-page":"102939","DOI":"10.1016\/j.ctrv.2025.102939","article-title":"Enhancing radiotherapy techniques for triple-negative breast cancer treatment","volume":"136","author":"Sarlak","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jpm11010003","article-title":"Ionizing radiation protein biomarkers in normal tissue and their correlation to radiosensitivity: protocol for a systematic review","volume":"11","author":"Dietz","year":"2021","journal-title":"J Pers Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1158\/0008-5472.CAN-06-0533","article-title":"Tumor cell radiosensitivity is a major determinant of tumor response to radiation","volume":"66","author":"Gerweck","year":"2006","journal-title":"Cancer Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1006\/excr.1999.4452","article-title":"Tumor radiosensitivity and apoptosis","volume":"248","author":"Zhivotovsky","year":"1999","journal-title":"Exp Cell Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/cancers16101942","article-title":"Clinical biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy: a systematic review","volume":"16","author":"Bleaney","year":"2024","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13014-019-1268-2","article-title":"Development and characterisation of acquired radioresistant breast cancer cell lines","volume":"14","author":"Gray","year":"2019","journal-title":"Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"166016","DOI":"10.1016\/j.bbadis.2020.166016","article-title":"Cancer cell metabolism: rewiring the mitochondrial hub","volume":"1867","author":"Oliveira","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.3390\/cancers12082252","article-title":"Targeting glucose metabolism to overcome resistance to anticancer chemotherapy in breast cancer","volume":"12","author":"Varghese","year":"2020","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/1535-7163.TARG-19-C016","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy resistant triple negative breast cancer","volume":"18","author":"Evans","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100949","DOI":"10.1016\/j.neo.2023.100949","article-title":"Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy","volume":"46","author":"Winter","year":"2023","journal-title":"Neoplasia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s12282-019-01027-5","article-title":"F-FDG PET imaging for monitoring the early anti-tumor effect of albendazole on triple-negative breast cancer","volume":"27","author":"Liu","year":"2020","journal-title":"Breast Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1309\/AJCP8AVF8FDPTZLH","article-title":"Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor expressing triple-negative breast carcinoma","volume":"138","author":"Sutton","year":"2012","journal-title":"Am J Clin Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/life14060682","article-title":"Prognostic and clinical significance of PD-L1, EGFR and androgen receptor (AR) expression in triple-negative breast cancer (TNBC) patients","volume":"14","author":"Medic-Milijic","year":"2024","journal-title":"Life"},{"key":"B26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/annonc\/mdz097.009","article-title":"The prognostic and predictive role of the androgen receptor in TNBC treated with neo-adjuvant chemotherapy","volume":"30","author":"Jongen","year":"2019","journal-title":"Ann Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-018-4813-z","article-title":"Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer","volume":"171","author":"Bardia","year":"2018","journal-title":"Breast Cancer Res Tr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.2016.71.3495","article-title":"Enzalutamide for the treatment of androgen receptor-expressing triple-negative breast cancer","volume":"36","author":"Traina","year":"2018","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0275279","DOI":"10.1371\/journal.pone.0275279","article-title":"Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00259-024-06866-9","article-title":"The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective","volume":"52","author":"Filippi","year":"2024","journal-title":"Eur J Nucl Med Mol I."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1634\/theoncologist.2018-0001","article-title":"Pretreatment 18F-FDG uptake heterogeneity predicts treatment outcome of first-line chemotherapy in patients with metastatic triple-negative breast cancer","volume":"23","author":"Gong","year":"2018","journal-title":"Oncologist"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.3390\/cancers16030667","article-title":"Head-to-head comparison of [18F]PSMA-1007 and [18F] FDG PET\/CT in patients with triple-negative breast cancer","volume":"51","author":"Andryszak","year":"2024","journal-title":"Eur J Nucl Med Mol I"},{"key":"B33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/RLU.0000000000001203","article-title":"Spectrum of the breast lesions with increased F-FDG uptake on PET\/CT","volume":"41","author":"Dong","year":"2016","journal-title":"Clin Nucl Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40644-021-00424-4","article-title":"Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET\/CT","volume":"21","author":"Kwon","year":"2021","journal-title":"Cancer Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1593\/tlo.11256","article-title":"Glut-1 expression correlates with basal-like breast cancer","volume":"4","author":"Hussein","year":"2011","journal-title":"Transl Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1002\/jcp.30189","article-title":"Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment","volume":"236","author":"Tsai","year":"2021","journal-title":"J Cell Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jcp.24698","article-title":"Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells","volume":"230","author":"Garrido","year":"2015","journal-title":"J Cell Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/1878-0261.12530","article-title":"SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity","volume":"13","author":"Liu","year":"2019","journal-title":"Mol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","article-title":"Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer","volume":"23","author":"Liang","year":"2024","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1007\/s11033-021-06414-w","article-title":"Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis","volume":"48","author":"Arundhathi","year":"2021","journal-title":"Mol Biol Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.7150\/jca.71592","article-title":"Hexokinase 2 is a pivot for lovastatin-induced glycolysis-to-autophagy reprogramming in triple-negative breast cancer cells","volume":"13","author":"Xue","year":"2022","journal-title":"J Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-2456","article-title":"SOX4 and SMARCA4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in triple negative breast cancer","author":"Khanna","year":"2021","journal-title":"Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/tcr.2019.01.37","article-title":"Downregulation of hexokinase 2 improves radiosensitivity of breast cancer","volume":"8","author":"Zhang","year":"2019","journal-title":"Transl Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"29375","DOI":"10.18632\/oncotarget.4910","article-title":"Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma","volume":"6","author":"Coelho","year":"2015","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2024.03.001","article-title":"GLUT and HK: two primary and essential key players in tumor glycolysis","volume":"100","author":"Yadav","year":"2024","journal-title":"Semin Cancer Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1871520623666230406111833","article-title":"3-Bromopyruvate inhibits the growth and glucose metabolism of TNBC xenografts in nude mice by targeting c-Myc","volume":"23","author":"Pan","year":"2023","journal-title":"Anticancer Agents Med Chem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41392-025-02405-6","article-title":"Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapy","volume":"10","author":"Park","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.critrevonc.2014.05.007","article-title":"Phosphofructokinase: a mediator of glycolytic flux in cancer progression","volume":"92","author":"Al Hasawi","year":"2014","journal-title":"Crit Rev Oncol Hemat."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.3892\/or.2021.8220","article-title":"Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer","volume":"47","author":"Inaishi","year":"2022","journal-title":"Oncol Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1042\/bj2510677","article-title":"Analysis of the phosphofructokinase subunits and isoenzymes in human-tissues","volume":"251","author":"Dunaway","year":"1988","journal-title":"Biochem J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00204-023-03456-w","article-title":"Coenzyme Q defeats NLRP3-mediated inflammation, EMT\/metastasis, and Warburg effects by inhibiting HIF-1\u03b1 expression in human triple-negative breast cancer cells","volume":"97","author":"Yang","year":"2023","journal-title":"Arch Toxicol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.15252\/embr.201643300","article-title":"PKM2, cancer metabolism, and the road ahead","volume":"17","author":"Dayton","year":"2016","journal-title":"EMBO Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13046-025-03343-5","article-title":"NONO interacts with nuclear PKM2 and directs histone H3 phosphorylation to promote triple-negative breast cancer metastasis","volume":"44","author":"Li","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-20-4190","article-title":"Targeting pyruvate kinase M2 phosphorylation reverses aggressive cancer phenotypes","volume":"81","author":"Apostolidi","year":"2021","journal-title":"Cancer Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1016\/j.apsb.2025.04.006","article-title":"Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery","volume":"15","author":"Wu","year":"2025","journal-title":"Acta Pharm Sin B."},{"key":"B58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-019-05376-9","article-title":"PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation","volume":"178","author":"Zhang","year":"2019","journal-title":"Breast Cancer Res Tr."},{"key":"B59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41586-024-08575-7","article-title":"Intrinsic electrical activity drives small-cell lung cancer progression","volume":"639","author":"Peinado","year":"2025","journal-title":"Nature"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e00421","DOI":"10.1002\/advs.202500421","article-title":"MYC\/TET3-regulated TMEM65 activates OXPHOS-SERPINB3 pathway to promote progression and cisplatin resistance in triple-negative breast cancer","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"103637","DOI":"10.1016\/j.redox.2025.103637","article-title":"OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer","volume":"83","author":"Uslu","year":"2025","journal-title":"Redox Biol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cmet.2017.09.009","article-title":"MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation","volume":"26","author":"Lee","year":"2017","journal-title":"Cell Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"216705","DOI":"10.1016\/j.canlet.2024.216705","article-title":"Cancer resistance and metastasis are maintained through oxidative phosphorylation","volume":"587","author":"Uslu","year":"2024","journal-title":"Cancer Lett"},{"key":"B65","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.tranon.2020.100905","article-title":"Targeting cancer-cell mitochondria and metabolism to improve radiotherapy response","volume":"14","author":"McCann","year":"2021","journal-title":"Transl Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"112203","DOI":"10.1016\/j.exger.2023.112203","article-title":"The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration","volume":"178","author":"Picca","year":"2023","journal-title":"Exp Gerontol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s12282-024-01554-w","article-title":"Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB","volume":"31","author":"Li","year":"2024","journal-title":"Breast Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1038\/s41388-022-02408-5","article-title":"Glutamine addiction promotes glucose oxidation in triple-negative breast cancer","volume":"41","author":"Quek","year":"2022","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12967-024-05946-6","article-title":"LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target","volume":"23","author":"Xue","year":"2025","journal-title":"J Transl Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fcell.2017.00027","article-title":"MCT1 in invasive ductal carcinoma: monocarboxylate metabolism and aggressive breast cancer","volume":"5","author":"Johnson","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1208\/s12248-018-0261-2","article-title":"Efficacy of the monocarboxylate transporter 1 inhibitor AR-C155858 in the murine 4T1 breast cancer tumor model","volume":"21","author":"Guan","year":"2019","journal-title":"AAPS J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1369-5266(03)00039-6","article-title":"The oxidative pentose phosphate pathway: structure and organisation","volume":"6","author":"Kruger","year":"2003","journal-title":"Curr Opin Plant Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.freeradbiomed.2012.05.006","article-title":"The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate","volume":"53","author":"Riganti","year":"2012","journal-title":"Free Radical Bio Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","article-title":"The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"},{"key":"B75","doi-asserted-by":"publisher","first-page":"119922","DOI":"10.1016\/j.bbamcr.2025.119922","article-title":"NUAKs facilitate mTOR-mediated NSCLC proliferation and metastasis by modulating glucose metabolism and inhibiting p53 activity","volume":"1872","author":"Yesupogu","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"694071","DOI":"10.3389\/fcell.2021.694071","article-title":"KRT6A Promotes lung cancer cell growth and invasion through MYC-regulated pentose phosphate pathway","volume":"9","author":"Che","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"116935","DOI":"10.1016\/j.biopha.2024.116935","article-title":"Glucose-6-phosphate dehydrogenase and transketolase: key factors in breast cancer progression and therapy","volume":"176","author":"Zhen","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B78","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/febs.16614","article-title":"Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer","volume":"290","author":"Li","year":"2023","journal-title":"FEBS J"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s12094-018-1833-4","article-title":"Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation","volume":"20","author":"Yang","year":"2018","journal-title":"Clin Transl Oncol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.7150\/ijbs.65555","article-title":"High expression of G6PD increases doxorubicin resistance in triple negative breast cancer cells by maintaining GSH level","volume":"18","author":"Luo","year":"2022","journal-title":"Int J Biol Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","article-title":"A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway","volume":"16","author":"Ghergurovich","year":"2020","journal-title":"Nat Chem Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"7346492","DOI":"10.1155\/2019\/7346492","article-title":"MYC expression and metabolic redox changes in cancer cells: a synergy able to induce chemoresistance","volume":"2019","author":"Marengo","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B83","doi-asserted-by":"publisher","first-page":"21797","DOI":"10.1074\/jbc.C000023200","article-title":"Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc","volume":"275","author":"Osthus","year":"2000","journal-title":"J Biol Chem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.3892\/etm.2021.10016","article-title":"Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway","volume":"21","author":"Yang","year":"2021","journal-title":"Exp Ther Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"11447","DOI":"10.3892\/etm.2022.11447","article-title":"3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc\/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells","volume":"24","author":"Li","year":"2022","journal-title":"Exp Ther Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7409","DOI":"10.1007\/s11033-022-07536-5","volume":"49","author":"Akar","year":"2022","journal-title":"Mol Biol Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"119716","DOI":"10.1016\/j.bbamcr.2024.119716","article-title":"METTL3 orchestrates glycolysis by stabilizing the c-Myc\/WDR5 complex in triple-negative breast cancer","volume":"1871","author":"Yuan","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"101808","DOI":"10.1016\/j.tranon.2023.101808","article-title":"Integrated multiomic data analysis reveals the clinical significance of TXNIP and contributing to immune microenvironment in triple negative breast cancer","volume":"39","author":"Gong","year":"2024","journal-title":"Transl Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/febs.15353","article-title":"Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications","volume":"288","author":"Iqbal","year":"2021","journal-title":"FEBS J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1073\/pnas.1501555112","article-title":"Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP","volume":"112","author":"Shen","year":"2015","journal-title":"P Natl Acad Sci USA."},{"key":"B91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/annonc\/mdw577.011","article-title":"Synergistic role of HIF-1\u03b1 and Nav1.5 in potentiating breast cancer metastasis","volume":"27","author":"Dewadas","year":"2016","journal-title":"Ann Oncol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11033-015-3858-x","article-title":"Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K","volume":"42","author":"Courtnay","year":"2015","journal-title":"Mol Biol Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.3390\/ijms20194742","article-title":"Causes and consequences of a glutamine induced normoxic HIF1 activity for the tumor metabolism","volume":"20","author":"Kappler","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11033-025-11231-6","article-title":"Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights","volume":"53","author":"Sharma","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s12094-023-03141-5","article-title":"Synergistic effect of chrysin and radiotherapy against triple-negative breast cancer (TNBC) cell lines","volume":"25","author":"Jafari","year":"2023","journal-title":"Clin Transl Oncol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jrr\/rrw012","article-title":"Hypoxia-inducible factor 1-mediated characteristic features of cancer cells for tumor radioresistance","volume":"57","author":"Harada","year":"2016","journal-title":"J Radiat Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41419-020-02952-6","article-title":"A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1\u03b1 and p53 activity in triple-negative breast cancer","volume":"11","author":"Du","year":"2020","journal-title":"Cell Death Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbcan.2017.01.002","article-title":"Cancer cell metabolism and mitochondria: nutrient plasticity for TCA cycle fueling","volume":"1868","author":"Corbet","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.81847","article-title":"Role of p53 in breast cancer progression: an insight into p53 targeted therapy","volume":"13","author":"Marvalim","year":"2023","journal-title":"Theranostics"},{"key":"B101","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12645-024-00285-z","article-title":"Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)","volume":"15","author":"Montazersaheb","year":"2024","journal-title":"Cancer Nanotechnol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1080\/07853890.2021.1966086","article-title":"Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population","volume":"53","author":"Wang","year":"2021","journal-title":"Ann Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.molcel.2019.08.006","article-title":"PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1","volume":"76","author":"Qian","year":"2019","journal-title":"Mol Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1365-2559.2012.04255.x","article-title":"Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer","volume":"61","author":"Iqbal","year":"2012","journal-title":"Histopathology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"21645","DOI":"10.1038\/s41598-024-69252-3","article-title":"A retrospective analysis suggests PTEN expression is associated with favorable clinicopathological features of breast cancer","volume":"14","author":"Derkyi-Kwarteng","year":"2024","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"667435","DOI":"10.3389\/fcell.2021.667435","article-title":"The absence of PTEN in breast cancer is a driver of MLN4924 resistance","volume":"9","author":"Du","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/1120009X.2024.2421701","article-title":"Transcriptional factor KLF9 overcomes 5-fluorouracil resistance in breast cancer via PTEN-dependent regulation of aerobic glycolysis","volume":"37","author":"Xu","year":"2025","journal-title":"J Chemother."},{"key":"B108","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-05940-w","article-title":"PI3K\u03b2 controls immune evasion in PTEN-deficient breast tumours","volume":"617","author":"Bergholz","year":"2023","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-025-07580-6","article-title":"Cancer-associated fibroblasts secrete CSF3 to promote TNBC progression via enhancing PGM2L1-dependent glycolysis reprogramming","volume":"16","author":"Qin","year":"2025","journal-title":"Cell Death Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","article-title":"NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction","volume":"43","author":"Li","year":"2024","journal-title":"J Exp Clin Canc Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"38344","DOI":"10.1038\/s41598-025-22197-7","article-title":"LINC02159 modulated the glycolysis and proliferation of TNBC cell via targeting miR-1285-3p\/G6PI axis","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.3892\/mmr.2016.4974","article-title":"Sensitization of hepatocellular carcinoma cells to irradiation by miR-34a through targeting lactate dehydrogenase-A","volume":"13","author":"Li","year":"2016","journal-title":"Mol Med Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1638897","DOI":"10.3389\/fimmu.2025.1638897","article-title":"Glycolysis-related radiosensitivity signature for predicting radiotherapy response in breast cancer","volume":"16","author":"Lin","year":"2025","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00726-023-03316-y","article-title":"Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer","volume":"55","author":"Liu","year":"2023","journal-title":"Amino Acids"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.3390\/cancers14153763","article-title":"A proof-of-concept inhibitor of endothelial lipase suppresses triple-negative breast cancer cells by hijacking the mitochondrial function","volume":"14","author":"Yang","year":"2022","journal-title":"Cancers"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e2114851119","DOI":"10.1073\/pnas.2114851119","article-title":"D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B117","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.3390\/ijms22094843","article-title":"Combined radionuclide therapy and immunotherapy for treatment of triple negative breast cancer","volume":"22","author":"Vito","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12964-023-01455-z","article-title":"The immune checkpoint TIGIT\/CD155 promotes the exhaustion of CD8+T cells in TNBC through glucose metabolic reprogramming mediated by PI3K\/AKT\/mTOR signaling","volume":"22","author":"Huang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/cells10081890","article-title":"Prognostic value of a glycolytic signature and its regulation by Y-box-binding protein 1 in triple-negative breast cancer","volume":"10","author":"Lai","year":"2021","journal-title":"Cells"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s42003-021-02805-8","article-title":"DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer","volume":"4","author":"Shen","year":"2021","journal-title":"Commun Biol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/cells9051253","article-title":"Targeting PI3K and AMPK\u03b1 signaling alone or in combination to enhance radiosensitivity of triple negative breast cancer","volume":"9","author":"Johnson","year":"2020","journal-title":"Cells"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/0008-5472.CAN-17-2090","article-title":"AMPK-Akt double-negative feedback loop in breast cancer cells regulates their adaptation to matrix deprivation","volume":"78","author":"Saha","year":"2018","journal-title":"Cancer Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1129682","DOI":"10.3389\/fonc.2023.1129682","article-title":"Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis","volume":"13","author":"Kempska","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1715716\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:21:42Z","timestamp":1776745302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1715716\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":123,"alternative-id":["10.3389\/fpubh.2026.1715716"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1715716","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"article-number":"1715716"}}